Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Nancy Jean Cox to Influenza Vaccines

This is a "connection" page, showing publications Nancy Jean Cox has written about Influenza Vaccines.

 
Connection Strength
 
 
 
4.909
 
  1. Fiore AE, Bridges CB, Cox NJ. Seasonal influenza vaccines. Curr Top Microbiol Immunol. 2009; 333:43-82.
    View in: PubMed
    Score: 0.320
  2. Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children--how do they compare? N Engl J Med. 2007 Feb 15; 356(7):729-31.
    View in: PubMed
    Score: 0.281
  3. Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, Cox N. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10748-52.
    View in: PubMed
    Score: 0.204
  4. Hurwitz ES, Haber M, Chang A, Shope T, Teo S, Ginsberg M, Waecker N, Cox NJ. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA. 2000 Oct 04; 284(13):1677-82.
    View in: PubMed
    Score: 0.181
  5. Cox NJ, Subbarao K. Influenza. Lancet. 1999 Oct 09; 354(9186):1277-82.
    View in: PubMed
    Score: 0.169
  6. Shu Y, Song Y, Wang D, Greene CM, Moen A, Lee CK, Chen Y, Xu X, McFarland J, Xin L, Bresee J, Zhou S, Chen T, Zhang R, Cox N. A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004-2014. BMC Public Health. 2019 May 10; 19(Suppl 3):520.
    View in: PubMed
    Score: 0.164
  7. Brydak LB, Rokicka-Milewska R, Jackowska T, Rudnicka H, Regnery H, Cox N. Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. Leuk Lymphoma. 1997 Jun; 26(1-2):163-9.
    View in: PubMed
    Score: 0.143
  8. Hampson A, Barr I, Cox N, Donis RO, Siddhivinayak H, Jernigan D, Katz J, McCauley J, Motta F, Odagiri T, Tam JS, Waddell A, Webby R, Ziegler T, Zhang W. Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015. Vaccine. 2017 02 22; 35(8):1104-1109.
    View in: PubMed
    Score: 0.140
  9. Jackowska T, Brydak L, Rokicka-Milewska R, Lukowska K, Gosk B, Rudnicka H, Regnery H, Cox N. [Vaccination against influenza in children with acute lymphoblastic leukemia]. Pediatr Pol. 1996 Apr; 71(4):301-6.
    View in: PubMed
    Score: 0.132
  10. Ridenour C, Johnson A, Winne E, Hossain J, Mateu-Petit G, Balish A, Santana W, Kim T, Davis C, Cox NJ, Barr JR, Donis RO, Villanueva J, Williams TL, Chen LM. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs. Influenza Other Respir Viruses. 2015 Sep; 9(5):263-70.
    View in: PubMed
    Score: 0.127
  11. Johnson A, Chen LM, Winne E, Santana W, Metcalfe MG, Mateu-Petit G, Ridenour C, Hossain MJ, Villanueva J, Zaki SR, Williams TL, Cox NJ, Barr JR, Donis RO. Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs. PLoS One. 2015; 10(6):e0128982.
    View in: PubMed
    Score: 0.125
  12. Klimov AI, Egorov AY, Gushchina MI, Medvedeva TE, Gamble WC, Rudenko LG, Alexandrova GI, Cox NJ. Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol. 1995 Jun; 76 ( Pt 6):1521-5.
    View in: PubMed
    Score: 0.125
  13. Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine. 1995; 13(15):1399-402.
    View in: PubMed
    Score: 0.121
  14. Reed C, Kim IK, Singleton JA, Chaves SS, Flannery B, Finelli L, Fry A, Burns E, Gargiullo P, Jernigan D, Cox N, Bresee J. Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep. 2014 Dec 12; 63(49):1151-4.
    View in: PubMed
    Score: 0.121
  15. Isakova-Sivak I, Chen LM, Bourgeois M, Matsuoka Y, Voeten JT, Heldens JG, van den Bosch H, Klimov A, Rudenko L, Cox NJ, Donis RO. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model. Clin Vaccine Immunol. 2014 May; 21(5):722-31.
    View in: PubMed
    Score: 0.115
  16. Barr IG, Russell C, Besselaar TG, Cox NJ, Daniels RS, Donis R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Schultz-Cherry S, Shu Y, Smith D, Tashiro M, Wang D, Webby R, Xu X, Ye Z, Zhang W. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine. 2014 Aug 20; 32(37):4713-25.
    View in: PubMed
    Score: 0.114
  17. Cox NJ, Trock SC, Burke SA. Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). Curr Top Microbiol Immunol. 2014; 385:119-36.
    View in: PubMed
    Score: 0.113
  18. Rudenko LG, Slepushkin AN, Monto AS, Kendal AP, Grigorieva EP, Burtseva EP, Rekstin AR, Beljaev AL, Bragina VE, Cox N, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993 Oct; 168(4):881-7.
    View in: PubMed
    Score: 0.111
  19. Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Smith D, Tashiro M, Xu X, Webby R, Wang D, Ye Z, Yuelong S, Zhang W, Cox N. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 2012 Oct 05; 30(45):6461-71.
    View in: PubMed
    Score: 0.103
  20. Gustin KM, Maines TR, Belser JA, van Hoeven N, Lu X, Dong L, Isakova-Sivak I, Chen LM, Voeten JT, Heldens JG, van den Bosch H, Cox NJ, Tumpey TM, Klimov AI, Rudenko L, Donis RO, Katz JM. Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. J Infect Dis. 2011 Nov 15; 204(10):1491-9.
    View in: PubMed
    Score: 0.097
  21. Isakova-Sivak I, Chen LM, Matsuoka Y, Voeten JT, Kiseleva I, Heldens JG, den Bosch Hv, Klimov A, Rudenko L, Cox NJ, Donis RO. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology. 2011 Apr 10; 412(2):297-305.
    View in: PubMed
    Score: 0.093
  22. Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, Guilfoyle K, Roseby S, Newman R, Collin R, Wallis C, Engelhardt OG, Wood JM, Le J, Manojkumar R, Pokorny BA, Silverman J, Devis R, Bucher D, Verity E, Agius C, Camuglia S, Ong C, Rockman S, Curtis A, Schoofs P, Zoueva O, Xie H, Li X, Lin Z, Ye Z, Chen LM, O'Neill E, Balish A, Lipatov AS, Guo Z, Isakova I, Davis CT, Rivailler P, Gustin KM, Belser JA, Maines TR, Tumpey TM, Xu X, Katz JM, Klimov A, Cox NJ, Donis RO. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine. 2011 Feb 17; 29(9):1836-43.
    View in: PubMed
    Score: 0.092
  23. Cox N, Donis R, Barr JR. Exposure science for viral diseases: 2009 H1N1 pandemic influenza virus. J Expo Sci Environ Epidemiol. 2011 Jan-Feb; 21(1):1-2.
    View in: PubMed
    Score: 0.091
  24. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010 Aug 06; 59(RR-8):1-62.
    View in: PubMed
    Score: 0.089
  25. Dong J, Matsuoka Y, Maines TR, Swayne DE, O'Neill E, Davis CT, Van-Hoven N, Balish A, Yu HJ, Katz JM, Klimov A, Cox N, Li DX, Wang Y, Guo YJ, Yang WZ, Donis RO, Shu YL. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses. 2009 Nov; 3(6):287-95.
    View in: PubMed
    Score: 0.085
  26. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009 Nov 12; 361(20):1945-52.
    View in: PubMed
    Score: 0.084
  27. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Jul 31; 58(RR-8):1-52.
    View in: PubMed
    Score: 0.083
  28. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008 Dec 08; 168(22):2405-14.
    View in: PubMed
    Score: 0.080
  29. Nachamkin I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H, Corcoran AT, Iskander JK, Schonberger LB, Chen RT. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis. 2008 Jul 15; 198(2):226-33.
    View in: PubMed
    Score: 0.077
  30. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007 Jul 13; 56(RR-6):1-54.
    View in: PubMed
    Score: 0.072
  31. Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J, DeStefano F, Shay D. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis. 2006 Oct 15; 194(8):1032-9.
    View in: PubMed
    Score: 0.068
  32. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 Jul 28; 55(RR-10):1-42.
    View in: PubMed
    Score: 0.068
  33. Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine. 2006 Nov 17; 24(47-48):6859-66.
    View in: PubMed
    Score: 0.067
  34. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004 May 28; 53(RR-6):1-40.
    View in: PubMed
    Score: 0.058
  35. Cox NJ, Kendal AP. Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. J Infect Dis. 1984 Feb; 149(2):194-200.
    View in: PubMed
    Score: 0.057
  36. Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003 Apr 25; 52(RR-8):1-34; quiz CE1-4.
    View in: PubMed
    Score: 0.054
  37. Matsuoka Y, Chen H, Cox N, Subbarao K, Beck J, Swayne D. Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza. Avian Dis. 2003; 47(3 Suppl):926-30.
    View in: PubMed
    Score: 0.053
  38. Chen H, Matsuoka Y, Chen Q, Cox NJ, Murphy BR, Subbarao K. Generation and characterization of an H9N2 cold-adapted reassortant as a vaccine candidate. Avian Dis. 2003; 47(3 Suppl):1127-30.
    View in: PubMed
    Score: 0.053
  39. Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2002 Apr 12; 51(RR-3):1-31.
    View in: PubMed
    Score: 0.050
  40. Bridges CB, Fukuda K, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2001 Apr 20; 50(RR-4):1-44.
    View in: PubMed
    Score: 0.047
  41. Rudenko LG, Arden NH, Grigorieva E, Naychin A, Rekstin A, Klimov AI, Donina S, Desheva J, Holman RC, DeGuzman A, Cox NJ, Katz JM. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine. 2000 Sep 15; 19(2-3):308-18.
    View in: PubMed
    Score: 0.045
  42. Bridges CB, Winquist AG, Fukuda K, Cox NJ, Singleton JA, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000 Apr 14; 49(RR-3):1-38; quiz CE1-7.
    View in: PubMed
    Score: 0.044
  43. Cox NJ. Prevention and control of influenza. Lancet. 1999 Dec; 354 Suppl:SIV30.
    View in: PubMed
    Score: 0.043
  44. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis. 1999 Sep-Oct; 5(5):659-71.
    View in: PubMed
    Score: 0.042
  45. Cox NJ, Maassab HF, Kendal AP. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Virology. 1979 Aug; 97(1):190-4.
    View in: PubMed
    Score: 0.042
  46. Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis. 1999 Mar; 28(3):541-7.
    View in: PubMed
    Score: 0.040
  47. Patriarca PA, Cox NJ. Influenza pandemic preparedness plan for the United States. J Infect Dis. 1997 Aug; 176 Suppl 1:S4-7.
    View in: PubMed
    Score: 0.036
  48. Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M, Wilker PR, Watanabe T, Watanabe S, Ito M, Iwatsuki-Horimoto K, Russell CA, James SL, Skepner E, Maher EA, Neumann G, Klimov AI, Kelso A, McCauley J, Wang D, Shu Y, Odagiri T, Tashiro M, Xu X, Wentworth DE, Katz JM, Cox NJ, Smith DJ, Kawaoka Y. Selection of antigenically advanced variants of seasonal influenza viruses. Nat Microbiol. 2016 05 23; 1(6):16058.
    View in: PubMed
    Score: 0.033
  49. Klimov AI, Cox NJ. PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. J Virol Methods. 1995 Mar; 52(1-2):41-9.
    View in: PubMed
    Score: 0.031
  50. Xu X, Kilbourne ED, Hall HE, Cox NJ. Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. J Infect Dis. 1994 Dec; 170(6):1432-8.
    View in: PubMed
    Score: 0.030
  51. Epperson S, Blanton L, Kniss K, Mustaquim D, Steffens C, Wallis T, Dhara R, Leon M, Perez A, Chaves SS, Elal AA, Gubareva L, Xu X, Villanueva J, Bresee J, Cox N, Finelli L, Brammer L. Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. MMWR Morb Mortal Wkly Rep. 2014 Jun 06; 63(22):483-90.
    View in: PubMed
    Score: 0.029
  52. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008 Apr 18; 320(5874):340-6.
    View in: PubMed
    Score: 0.019
  53. Cox NJ, Kitame F, Klimov A, Koennecke I, Kendal AP. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza virus: detection of mutations in all genes of the A/Ann Arbor/6/60 (H2N2) mutant vaccine donor strain. Microb Pathog. 1986 Aug; 1(4):387-97.
    View in: PubMed
    Score: 0.017
  54. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, Likos AM, Posey DL, Klimov A, Lindstrom SE, Balish A, Medina MJ, Wallis TR, Guarner J, Paddock CD, Shieh WJ, Zaki SR, Sejvar JJ, Shay DK, Harper SA, Cox NJ, Fukuda K, Uyeki TM. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005 Dec 15; 353(24):2559-67.
    View in: PubMed
    Score: 0.016
  55. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol. 1999 Jul; 73(7):5903-11.
    View in: PubMed
    Score: 0.010
  56. Williams RJ, Cox NJ, Regnery HL, Noah DL, Khan AS, Miller JM, Copley GB, Ice JS, Wright JA. Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. Mil Med. 1997 Feb; 162(2):82-6.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.